The prevalence of the HNF-1α G319S mutation in Canadian aboriginal youth with type 2 diabetes

Diabetes Care

Volumn 25, Issue 12, 2002, Pages 2202-2206

  Sellers, Elizabeth A C ^a   Triggs Raine, Barbara ^b   Rockman Greenberg, Cheryl ^b   Dean, Heather J ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN; NUCLEAR FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1BETA; NUCLEAR PROTEIN; TCF1 PROTEIN, HUMAN; TCF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ABORIGINE; ACANTHOSIS NIGRICANS; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANADA; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY; PREVALENCE; WILD TYPE; ADOLESCENT; AMERICAN INDIAN; AMINO ACID SUBSTITUTION; BLOOD; CHILD; FEMALE; GENETICS; HOMOZYGOTE; MISSENSE MUTATION;

ADOLESCENT; ALLELES; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; AMINO ACID SUBSTITUTION; CANADA; CHILD; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HOMOZYGOTE; HUMANS; MUTATION, MISSENSE; NUCLEAR PROTEINS; PREGNANCY; TRANSCRIPTION FACTORS;

EID: 0013258825     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.12.2202     Document Type: Article

References (19)

1. Libman I, Arslanian SA: Type 2 diabetes mellitus: no longer just adults. Pediatr Ann 28:589-593, 1999
2. Dean H: NIDDM-Y in First Nation children in Canada. Clin Pediatr (Phila) 37:89-96, 1998
3. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Leviseiti M, Bonner-Weir S, Bell GI, Yahiv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest 101:2215-2222, 1998
4. Okita K, Yang Q, Yamagata K, Hangenfeldt KA, Miyagawa J, Kajimoto Y, Nakajima H, Namba M, Wollheim CB, Hanafusa T, Matsuzawa Y: Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta. Biochem Biophys Res Commun 263:566-569, 1999
5. Yang Q, Yamagata K, Yamamoto K, Miyagawa J, Takeda J, Iwasaki N, Iwabashi H, Yoshiuchi I, Namba M, Mivazaki J, Hanafusa T, Matsuzawa Y: Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor. Biochem Biophys Res Commun 266:196-202, 1999
6. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckman JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 9:418-423, 1995
7. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj W, Chevre JC, Boccio V, Cox RD, Lathrop GM, Dussoix P, Phillippe J, Timsit J, Charpentier G, Velho G, Bell GI, Froguel P: Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6:583-586, 1997
8. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj W, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI, et al: Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
9. Iwasaki N, Oda N, Ogata M, Hara M, Hinokio Y, Oda Y, Yamagata K, Kanematsu S, Ohgawara H, Omori Y, Bell GI: Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 46:1504-1508, 1997
10. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B: The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84:1077-1082, 1999
11. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 20:185-187, 1997
12. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM: Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Int J Obes Relat Metab Disord 24:1062-1064, 2000
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentraticns in man. Diabetologia 28:412-419, 1985
14. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
15. Hegele RA, Hanley AJ, Zinman B, Harris SB, Anderson CM: Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians (Letter). Diabetes Care 22:2095-2096, 1999
16. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT: β-Cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations. Diabetes 50 (Suppl. 1):S101-S107, 2001
17. Martens P: The Health and Health Care Use of Registered First Nations People Living in Manitoba: A Population-Based Study. Winnipeg, Canada, The Manitoba Centre for Health Policy, 2002
18. Tack CJ, Ellard S, Hattersley AT: A severe clinical phenotype results from the co-inheritance of type 2 susceptibility genes and a hepatocyte nuclear factor-1α mutation. Diabetes Care 23:424-425, 2000
19. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K, Hanley AJ, Zinman B, Harris SB, Barrett PH, Hegele RA: HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A 99:4614-4619, 2002